Morgan Stanley’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Hold
129,217
﹤0.01% 5756
2025
Q4
$211K Sell
129,217
-1,355
-1% -$1.96K ﹤0.01% 5912
2025
Q3
$140K Sell
130,572
-638
-0.5% -$715 ﹤0.01% 6023
2025
Q2
$152K Hold
131,210
﹤0.01% 5957
2025
Q1
$121K Sell
131,210
-1,179
-0.9% -$1.17K ﹤0.01% 5925
2024
Q4
$114K Buy
132,389
+670
+0.5% +$943 ﹤0.01% 6009
2024
Q3
$219K Buy
131,719
+118
+0.1% +$205 ﹤0.01% 5722
2024
Q2
$212K Sell
131,601
-91
-0.1% -$184 ﹤0.01% 5648
2024
Q1
$302K Sell
131,692
-131,842
-50% -$305K ﹤0.01% 5556
2023
Q4
$593K Buy
263,534
+130,390
+98% +$315K ﹤0.01% 5551
2023
Q3
$402K Sell
133,144
-584
-0.4% -$2.21K ﹤0.01% 5267
2023
Q2
$551K Hold
133,728
﹤0.01% 5157
2023
Q1
$501K Buy
133,728
+247
+0.2% +$1.19K ﹤0.01% 5252
2022
Q4
$746K Sell
133,481
-3,107
-2% -$18.3K ﹤0.01% 5031
2022
Q3
$907K Sell
136,588
-4,359
-3% -$35.3K ﹤0.01% 4932
2022
Q2
$1.4M Sell
140,947
-4,193
-3% -$40K ﹤0.01% 4787
2022
Q1
$2.76M Sell
145,140
-10,192
-7% -$160K ﹤0.01% 4270
2021
Q4
$2.76M Sell
155,332
-11,529
-7% -$345K ﹤0.01% 4309
2021
Q3
$6.18M Sell
166,861
-37,199
-18% -$1.65M ﹤0.01% 3453
2021
Q2
$12.1M Buy
204,060
+57,660
+39% +$3.49M ﹤0.01% 2767
2021
Q1
$9.81M Sell
146,400
-39,168
-21% -$3.07M ﹤0.01% 2678
2020
Q4
$11.2M Buy
185,568
+182,667
+6,297% +$12.5M ﹤0.01% 2387
2020
Q3
$230K Sell
2,901
-271
-9% -$21.6K ﹤0.01% 5032
2020
Q2
$199K Buy
3,172
+660
+26% +$38.4K ﹤0.01% 5079
2020
Q1
$132K Sell
2,512
-11,640
-82% -$1.15M ﹤0.01% 5070
2019
Q4
$1.71M Buy
14,152
+6,604
+87% +$950K ﹤0.01% 4157
2019
Q3
$1.37M Buy
7,548
+2,990
+66% +$421K ﹤0.01% 4088
2019
Q2
$593K Sell
4,558
-579
-11% -$104K ﹤0.01% 4517
2019
Q1
$1.25M Sell
5,137
-4,602
-47% -$1.22M ﹤0.01% 3960
2018
Q4
$1.85M Sell
9,739
-961
-9% -$234K ﹤0.01% 3836
2018
Q3
$3.51M Sell
10,700
-4,930
-32% -$1.51M ﹤0.01% 3544
2018
Q2
$4.88M Buy
15,630
+4,438
+40% +$1.36M ﹤0.01% 3175
2018
Q1
$2.73M Buy
11,192
+145
+1% +$40.7K ﹤0.01% 3679
2017
Q4
$3.34M Buy
11,047
+2,388
+28% +$665K ﹤0.01% 3525
2017
Q3
$2.29M Buy
8,659
+1,176
+16% +$340K ﹤0.01% 3741
2017
Q2
$1.97M Sell
7,483
-389
-5% -$97.4K ﹤0.01% 3807
2017
Q1
$2.83M Sell
7,872
-2,434
-24% -$753K ﹤0.01% 3484
2016
Q4
$2.97M Buy
10,306
+522
+5% +$162K ﹤0.01% 3541
2016
Q3
$3.33M Sell
9,784
-740
-7% -$270K ﹤0.01% 3061
2016
Q2
$4.47M Buy
10,524
+1,039
+11% +$428K ﹤0.01% 2724
2016
Q1
$3.03M Buy
9,485
+1,658
+21% +$566K ﹤0.01% 2982
2015
Q4
$4.06M Buy
7,827
+2,887
+58% +$1.07M ﹤0.01% 2878
2015
Q3
$1.45M Sell
4,940
-8,092
-62% -$2.88M ﹤0.01% 3795
2015
Q2
$5.12M Buy
13,032
+895
+7% +$316K ﹤0.01% 2776
2015
Q1
$3.67M Buy
12,137
+10,496
+640% +$2.56M ﹤0.01% 3041
2014
Q4
$365K Sell
1,641
-2,781
-63% -$574K ﹤0.01% 4891
2014
Q3
$1.03M Buy
4,422
+1,978
+81% +$498K ﹤0.01% 4005
2014
Q2
$541K Buy
2,444
+1,376
+129% +$306K ﹤0.01% 4522
2014
Q1
$337K Buy
1,068
+815
+322% +$260K ﹤0.01% 4821
2013
Q4
$66K Sell
253
-182
-42% -$39.9K ﹤0.01% 5499
2013
Q3
$63K Sell
435
-1,304
-75% -$158K ﹤0.01% 5168
2013
Q2
$264K Buy
+1,739
New +$238K ﹤0.01% 4671

Other funds holding TXMD